Phase 3 Trials

Business

Pfizer's $23 Billion Oncology Bet: CEO Albert Bourla's Post-Pandemic Quest to 'Save the World from Cancer'

After the COVID-19 windfall subsided, Pfizer CEO Albert Bourla is steering the pharmaceutical giant into a high-stakes, $23 billion pivot to cancer research. Facing a looming patent cliff and plummeting vaccine revenue, Bourla is betting on scientific innovation to secure the company's future—and redefine cancer treatment.

Jan 30, 2026

Business

Eli Lilly Bets Big on Pennsylvania with $3.5 Billion Plant for Next-Gen Weight-Loss Drugs

Pharmaceutical giant Eli Lilly announces a massive $3.5 billion investment in a new Pennsylvania manufacturing facility, aiming to scale up production of its blockbuster weight-loss therapies like retatrutide amid soaring global demand.

Jan 30, 2026

Business

Geron Sees Price Target Cut to $3 by TD Cowen Ahead of Q4, But Buy Rating Stays

Analyst Tara Bancroft of TD Cowen lowered the firm's price target on Geron Corporation (GERN) from $4 to $3, maintaining a Buy rating ahead of the biotech's fourth-quarter results. The move reflects a model update as the company navigates mixed commercial progress for its blood cancer drug RYTELO.

Jan 30, 2026

Business

Huntington Ingalls' Naval Legacy on Display as USS John F. Kennedy Begins Sea Trials

The commencement of sea trials for the nuclear-powered aircraft carrier USS John F. Kennedy coincides with the 140th anniversary of its builder, Newport News Shipbuilding, underscoring Huntington Ingalls Industries' entrenched role in U.S. naval defense and its long-term investment profile.

Jan 30, 2026

Business

Enphase Energy Announces Restructuring and New Storage Partnership Amid Investor Scrutiny

Enphase Energy unveils a strategic restructuring involving workforce reductions and a new home battery partnership, as the solar technology firm navigates a challenging market and mixed investor returns.

Jan 30, 2026

Business

Precious Metals Rally Stalls: Gold Plunges to $5,100, Silver Tumbles 13% in Sharp Reversal

A blistering rally in gold and silver came to an abrupt halt Friday, with prices tumbling sharply as market volatility surged and analysts warned the historic run may be entering a precarious phase.

Jan 30, 2026

Business

GSI Technology Posts Q3 Revenue Growth Amid Strategic Pivot to Defense and Edge AI

GSI Technology Inc. reports a 12% year-over-year revenue increase for Q3 2026, driven by defense sector adoption of its Gemini-II APU. While R&D investments pressure margins, the company highlights a strong cash position and expanding applications in smart cities and robotics.

Jan 30, 2026

Business

Netflix's Earnings: Strong Results, Cautious Outlook, and an $83 Billion Bet on the Future

Netflix delivered solid Q4 earnings but saw its stock dip as it guided for slower revenue growth. The streaming giant's strategic pivot to a mature phase is underscored by its aggressive all-cash bid for Warner Bros. Discovery, a move that promises content dominance but adds significant debt.

Jan 30, 2026

Business

Wealth Manager's $2.7 Million Bet on 2030 Bond ETF Signals Focus on Predictable Income

Howard Wealth Management's significant purchase of the Invesco BulletShares 2030 Corporate Bond ETF (BSCU) highlights a strategic move towards defined-maturity fixed income, underscoring a disciplined approach to building cash flow ladders in a volatile rate environment.

Jan 30, 2026

Business

Google's Project Genie Shakes Up 3D Creation Arena, Casting Shadow Over Unity's Future

Google's unveiling of Project Genie, an AI tool for generating interactive 3D worlds, sends ripples through the game development sector, directly challenging incumbent platform Unity Software. The announcement coincides with a period of intense volatility and investor scrutiny for Unity, raising fundamental questions about its long-term strategic position in an AI-driven landscape.

Feb 2, 2026

Business

Burger King Sets Sights on 4,000+ Chinese Restaurants by 2035 in Major Expansion Push

Following the finalization of a joint venture with investment firm CPE, Burger King's parent company RBI has reaffirmed ambitious plans to more than triple its footprint in China over the next decade, backed by a $350 million investment.

Feb 2, 2026

Business

Schwab's New Core Bond ETF Delivers Steady 4.32% Monthly Yield, Appealing to Income-Focused Investors

The actively managed Schwab Core Bond ETF (SCCR), launched in early 2025, is gaining attention for its monthly distributions and a current yield of 4.32%. The fund focuses on high-quality U.S. dollar-denominated debt, offering retirees and other investors a potential source of predictable income in a shifting rate environment.

Feb 2, 2026

Business

3M's Rocky Road: Analysts Hold Steady Despite Stock Lagging Behind Market Rally

While 3M shares have significantly underperformed the broader market and its industrial peers over the past year, Wall Street maintains a cautiously optimistic stance, betting on the diversified giant's long-term recovery and earnings resilience.

Feb 2, 2026

Business

Myriad and AceTrader Launch $30K Prediction Contest Around High-Stakes Crypto Trading Showdown

Prediction market platform Myriad partners with crypto prop firm AceTrader, allowing users to bet on the outcomes of a million-dollar trader competition while competing for a share of a $30,000 prize pool.

Feb 2, 2026

Business

Seeking Stability: Three Dividend Stocks Offering Yields Up to 3.5% in a Volatile Market

As major indexes climb and oil prices fluctuate, investors are turning to dividend payers for reliable income. We analyze three stocks with yields between 3% and 3.5%, examining their sustainability and growth prospects.

Feb 2, 2026

Business

Burger King China Shifts to Local Control: CPE Invests $350M for Majority Stake in Ambitious Expansion Drive

Restaurant Brands International (RBI) has formed a joint venture with private equity firm CPE, ceding majority control of Burger King's China operations in a deal aimed at turbocharging growth. The partnership targets a more than tripling of restaurants to over 4,000 by 2035, leveraging local expertise and capital.

Feb 2, 2026

Sanofi's Long-Delayed Rare Disease Drug Shows Promise for Neurological Gaucher, Falters in Fabry

After a decade of development and multiple clinical setbacks, Sanofi's venglustat has met its primary goal in a Phase 3 trial for Type 3 Gaucher disease, offering new hope for neurological symptoms. The drug, however, failed a separate late-stage study for Fabry disease.

Feb 2, 2026

Business

Crypto Markets See Broad Sell-Off: CoinDesk 20 Index Plunges 9.3% as Ethereum Leads Decline

The CoinDesk 20 Index, a key benchmark for the digital asset market, fell sharply over the weekend, with every constituent in the red. Ethereum's 13.9% drop was a primary driver of the downturn.

Feb 2, 2026

Business

Craft Spirits Consolidation: Kentucky's Casey Jones Distillery Acquired by Multi-State Beverage Group B3

Amidst a turbulent period for craft distilling, the founders of Casey Jones Distillery in Hopkinsville, KY, have sold their bourbon and moonshine operation to Pennsylvania-based B3 Beverage Company, securing the legacy of a family-run business while joining a growing portfolio of craft breweries and distilleries.

Feb 2, 2026

Business

Investors Pull Record $1.73B From Crypto Funds as Rate Cut Hopes Fade

Digital asset investment products witnessed their largest weekly capital flight since late 2025, with Bitcoin and Ethereum bearing the brunt of a $1.73 billion exodus. The sell-off, concentrated in the U.S., underscores a sharp pivot in risk appetite amid shifting macroeconomic winds, though Solana and select regions bucked the trend with modest inflows.

Feb 2, 2026